Proteomic Study of Plasma Exosomes in Patients With Diabetic Retinopathy
- Conditions
- Diabetic Retinopathy
- Registration Number
- NCT06188013
- Lead Sponsor
- Xuanwu Hospital, Beijing
- Brief Summary
Objective: Explore the biomarkers related to proliferative diabetic retinopathy by analyzing the protein expression profile changes of plasma exosomes in patients with difference phases of diabetic retinopathy, and investigate potential molecular mechanisms and therapeutic targets. Methods: Enrich exosomes from plasma by column extraction method. NTA, WB and TEM were used to characterize the obtained exosomes, and exosome proteinomics was performed by chromatography⁃mass spectrometry. Corhorts: The study was divided into four groups: a healthy control group, a diabetic without diabetic retinopathy group, a non-proliferative diabetic retinopathy group, and a proliferative diabetic retinopathy group, with 6 cases in each group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 24
- Healthy volunteers without diabetes/ Senile cataract patients without diabetes;
- Patients with diabetes who are diagnosed without DR, NPDR, and PDR by mydriatic fundus photography (or FFA);
- Patients with systemic diseases such as cancer, immune diseases, infectious diseases, and blood diseases;
- Patients with cerebral infarction, myocardial infarction and other cardiovascular and cerebrovascular diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method differential proteins of exosomes December,2023-June,2024 Exosomes were extracted and isolated from plasma, proteomics analysis of proteins in exosomes was performed to compare the number of types of changes in exosomal proteins of the four groups and to identify proteins that were up-regulated and/or down-regulated, and the relationship between the proteins and diabetic retinopathy was then analysed to look for possible mechanisms and therapeutic targets for diabetic retinopathy.
- Secondary Outcome Measures
Name Time Method